Central blood pressure for the management of hypertension: Is it a practical clinical tool in current practice?

Cheng, Hao-Min and Chuang, Shao-Yuan and Wang, Tzung-Dau and Kario, Kazuomi and Buranakitjaroen, Peera and Chia, Yook-Chin and Divinagracia, Romeo and Hoshide, Satoshi and Minh, Huynh Van and Nailes, Jennifer and Park, Sungha and Shin, Jinho and Siddique, Saulat and Sison, Jorge and Soenarta, Arieska Ann and Sogunuru, Guru Prasad and Sukonthasarn, Apichard and Tay, Jam Chin and Teo, Boon Wee and Turana, Yuda and Verma, Narsingh and Zhang, Yuqing and Wang, Ji-Guang and Chen, Chen-Huan (2020) Central blood pressure for the management of hypertension: Is it a practical clinical tool in current practice? Journal of Clinical Hypertension, 22 (3). pp. 391-406. ISSN 1524-6175, DOI https://doi.org/10.1111/jch.13758.

Full text not available from this repository.


Since noninvasive central blood pressure (BP) measuring devices are readily available, central BP has gained growing attention regarding its clinical application in the management of hypertension. The disagreement between central and peripheral BP has long been recognized. Some previous studies showed that noninvasive central BP may be better than the conventional brachial BP in association with target organ damages and long-term cardiovascular outcomes. Recent studies further suggest that the central BP strategy for confirming a diagnosis of hypertension may be more cost-effective than the conventional strategy, and guidance of hypertension management with central BP may result in less use of medications to achieve BP control. Despite the use of central BP being promising, more randomized controlled studies comparing central BP-guided therapeutic strategies with conventional care for cardiovascular events reduction are required because noninvasive central and brachial BP measures are conveniently available. In this brief review, the rationale supporting the utility of central BP in clinical practice and relating challenges are summarized.

Item Type: Article
Funders: Omron Healthcare, AD, Fukuda Denshi Co. Ltd., Pfizer, Abbott Laboratories
Uncontrolled Keywords: Brachial BP; Central BP; Diagnosis; High BP; Hypertension; Management; Peripheral BP
Subjects: R Medicine > R Medicine (General)
Divisions: Faculty of Medicine > Primary Care Medicine Department
Depositing User: Ms Zaharah Ramly
Date Deposited: 10 Mar 2023 02:50
Last Modified: 10 Mar 2023 02:50
URI: http://eprints.um.edu.my/id/eprint/37215

Actions (login required)

View Item View Item